Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.
JAMA Netw Open. 2019 Jan 4;2(1):e187223. doi: 10.1001/jamanetworkopen.2018.7223.
Whether low levels of low-density lipoprotein cholesterol (LDL-C) are associated with increased risk of sepsis and poorer outcomes is unknown.
To examine the association between LDL-C levels and risk of sepsis among patients admitted to the hospital with infection.
DESIGN, SETTING, AND PARTICIPANTS: Cohort study in which deidentified electronic health records were used to define a cohort of patients admitted to Vanderbilt University Medical Center, Nashville, Tennessee, with infection. Patients were white adults, had a code indicating infection from the International Classification of Diseases, Ninth Revision, Clinical Modification, and received an antibiotic within 1 day of hospital admission (N = 61 502). Data were collected from January 1, 1993, through December 31, 2017, and analyzed from January 24 through October 31, 2018.
Clinically measured LDL-C levels (excluding measurements <1 year before hospital admission and those associated with acute illness) and a genetic risk score (GRS).
The primary outcome was sepsis; secondary outcomes included admission to an intensive care unit (ICU) and in-hospital death.
Among the 3961 patients with clinically measured LDL-C levels (57.8% women; mean [SD] age, 64.1 [15.9] years) and the 7804 with a GRS for LDL-C (54.0% men; mean [SD] age, 59.8 [15.2] years), lower measured LDL-C levels were significantly associated with increased risk of sepsis (odds ratio [OR], 0.86; 95% CI, 0.79-0.94; P = .001) and ICU admission (OR, 0.85; 95% CI, 0.76-0.96; P = .008), but not in-hospital mortality (OR, 0.80; 95% CI, 0.63-1.00; P = .06); however, none of these associations were statistically significant after adjustment for age, sex, and comorbidity variables (OR for risk of sepsis, 0.96 [95% CI, 0.88-1.06]; OR for ICU admission, 0.94 [95% CI, 0.83-1.06]; OR for in-hospital death, 0.97 [95% CI, 0.76-1.22]; P > .05 for all). The LDL-C GRS correlated with measured LDL-C levels (r = 0.24; P < 2.2 × 10-16) but was not significantly associated with any of the outcomes.
Results of this study suggest that lower measured LDL-C levels were significantly associated with increased risk of sepsis and admission to ICU in patients admitted to the hospital with infection; however, this association was due to comorbidities because both clinical models adjusted for confounders, and the genetic model showed no increased risk. Levels of LDL-C do not appear to directly alter the risk of sepsis or poor outcomes in patients hospitalized with infection.
低密度脂蛋白胆固醇(LDL-C)水平低是否与脓毒症风险增加和预后较差有关尚不清楚。
研究住院感染患者 LDL-C 水平与脓毒症风险之间的关系。
设计、地点和参与者:这项队列研究使用匿名电子健康记录定义了田纳西州纳什维尔范德比尔特大学医学中心因感染而入院的患者队列。患者为白人成年人,国际疾病分类第 9 版临床修订版中有感染代码,且入院后 1 天内接受了抗生素治疗(N = 61 502)。数据收集于 1993 年 1 月 1 日至 2017 年 12 月 31 日,分析于 2018 年 1 月 24 日至 10 月 31 日进行。
临床测量的 LDL-C 水平(排除入院前 1 年内和与急性疾病相关的测量值)和遗传风险评分(GRS)。
主要结局为脓毒症;次要结局包括入住重症监护病房(ICU)和院内死亡。
在 3961 例具有临床测量 LDL-C 水平的患者(57.8%为女性;平均[SD]年龄,64.1[15.9]岁)和 7804 例具有 LDL-C GRS 的患者(54.0%为男性;平均[SD]年龄,59.8[15.2]岁)中,较低的 LDL-C 水平与脓毒症风险增加显著相关(比值比[OR],0.86;95%置信区间[CI],0.79-0.94;P = .001)和 ICU 入院(OR,0.85;95% CI,0.76-0.96;P = .008),但与院内死亡率无关(OR,0.80;95% CI,0.63-1.00;P = .06);然而,在调整年龄、性别和合并症变量后,这些关联均无统计学意义(脓毒症风险的 OR,0.96 [95% CI,0.88-1.06];ICU 入院的 OR,0.94 [95% CI,0.83-1.06];院内死亡的 OR,0.97 [95% CI,0.76-1.22];所有 P 值均>.05)。LDL-C GRS 与测量的 LDL-C 水平相关(r = 0.24;P < 2.2 × 10-16),但与任何结局均无显著相关性。
这项研究的结果表明,与感染住院患者的脓毒症风险和 ICU 入院相关的是 LDL-C 水平降低;然而,这种关联是由于合并症所致,因为两种临床模型都调整了混杂因素,而遗传模型并未显示出风险增加。LDL-C 水平似乎不会直接改变感染住院患者的脓毒症或不良结局风险。